Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal care to improve patient outcomes.

Nanoscope Therapeutics establishes a Vision Advisory Committee to enhance retinal care and drive innovative therapies for vision restoration.

Phase 1/2 interim results highlight real-world functional enhancements in patients with severe LCA5-related Leber congenital amaurosis.

Breye Therapeutics advances danegaptide, a novel oral therapy for non-proliferative diabetic retinopathy, showing promise in early clinical trials.

PYC Therapeutics advances VP-001 for retinitis pigmentosa, securing FDA guidance for its upcoming registrational trial design and study parameters.

Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of Ophthalmology Times.

One of my favorite components of my career has been building a leading clinical trial program at our practice. Clinical science has allowed me to offer cutting-edge treatments in my community while ...

Looking at innovative tools and their applications in different disease states can help to think creatively about ways to benefit patients in retina care.

Free diabetic retinopathy (DR) screenings begin this week through a collaboration between Avant Technologies, Ainnova Tech and Grupo Dökka, Fischel Pharmacies and La Bomba Pharmacies, according to a ...

Nassim Abreu, MD, reported the initial experience while applying panretinal photocoagulation (PRP) using the new LYNX pattern laser indirect ophthalmoscope (LIO) (Norlase). Abreu, who is an associate ...

Yasha Modi, MD, from NYU Langone Health, New York, New York, and Carl Danzig, MD, from the Rand Eye Institute, Deerfield Beach, Florida, participated in an opinion panel for Modern Retina. They ...

Newsletter Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.